http://reut.rs/1uK6L8S http://nyti.ms/1BPvTxg http://wapo.st/1uK6Itz iven-to-10-volunteers-and-there-are-no-red-flags-yet The 1st human trial of an EVD vaccine has so far produced no adverse effects, according to Anthony Fauci, director of the NIH's [National Institute of Health] Institute of Allergy and Infectious Diseases. The phase I trial is being conducted at an NIH facility in Bethesda, Maryland [USA] and is focused on building scientific evidence that the vaccine is safe in humans. It was developed by British drug-maker GlaxoSmithKline in conjunction with the NIH. The vaccine is based on a chimpanzee cold virus, chimp adenovirus type 3, which is being used as a carrier of pieces of genetic material of 2 Ebola strains: Sudan and Zaire; the latter is currently causing the massive epidemic in West Africa. The Ebola genetic material in the virus is not able to replicate and poses no harm to the people who receive it.
9/18/2014
Untested Ebola vaccine could be readied for Africa bound troops
http://reut.rs/1uK6L8S http://nyti.ms/1BPvTxg http://wapo.st/1uK6Itz iven-to-10-volunteers-and-there-are-no-red-flags-yet The 1st human trial of an EVD vaccine has so far produced no adverse effects, according to Anthony Fauci, director of the NIH's [National Institute of Health] Institute of Allergy and Infectious Diseases. The phase I trial is being conducted at an NIH facility in Bethesda, Maryland [USA] and is focused on building scientific evidence that the vaccine is safe in humans. It was developed by British drug-maker GlaxoSmithKline in conjunction with the NIH. The vaccine is based on a chimpanzee cold virus, chimp adenovirus type 3, which is being used as a carrier of pieces of genetic material of 2 Ebola strains: Sudan and Zaire; the latter is currently causing the massive epidemic in West Africa. The Ebola genetic material in the virus is not able to replicate and poses no harm to the people who receive it.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment